Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
62
IMAX Quote, Financials, Valuation and Earnings
Last price:
$24.53
Seasonality move
:
10.75%
Day range:
$24.35 - $24.88
52-week range:
$13.20 - $26.84
Dividend yield:
0%
P/E ratio:
55.73x
P/S ratio:
3.83x
P/B ratio:
4.46x
Volume:
572.2K
Avg. volume:
539.5K
1-year change:
64.56%
Market cap:
$1.3B
Revenue:
$374.8M
EPS (TTM):
$0.44
Analysts' Opinion
-
Consensus RatingImax has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $27.27, Imax has an estimated upside of 11.23% from its current price of $24.52.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing 34.75% downside risk from its current price of $24.52.
Fair Value
-
According to the consensus of 8 analysts, Imax has 11.23% upside to fair value with a price target of $27.27 per share.
IMAX vs. S&P 500
-
Over the past 5 trading days, Imax has underperformed the S&P 500 by -3.89% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Imax does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Imax revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Imax reported revenues of $91.5M.
Earnings Growth
-
Imax has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Imax reported earnings per share of $0.26.
Enterprise value:
1.5B
EV / Invested capital:
2.39x
Price / LTM sales:
3.83x
EV / EBIT:
39.46x
EV / Revenue:
4.46x
PEG ratio (5yr expected):
0.13x
EV / Free cash flow:
81.83x
Price / Operating cash flow:
70.18x
Enterprise value / EBITDA:
15.19x
Gross Profit (TTM):
$185.5M
Return On Assets:
2.8%
Net Income Margin (TTM):
6.74%
Return On Equity:
6.67%
Return On Invested Capital:
3.75%
Operating Margin:
19.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $311.3M | $386.9M | $345.6M | $103.9M | $91.5M | |
| Gross Profit | $171.5M | $219.5M | $185.5M | $62.7M | $51M | |
| Operating Income | $23.1M | $48.8M | $35.6M | $22.5M | $18.2M | |
| EBITDA | $72.7M | $117.8M | $101.5M | $42.3M | $34.9M | |
| Diluted EPS | -$0.27 | $0.46 | $0.44 | $0.22 | $0.26 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $594.8M | $503.6M | $428.6M | $488.3M | $467.6M | |
| Total Assets | $1B | $871.2M | $800.2M | $850.9M | $847.6M | |
| Current Liabilities | $513.7M | $209.8M | $220.9M | $251.7M | $237.2M | |
| Total Liabilities | $532.4M | $450.7M | $462.3M | $493.5M | $479.8M | |
| Total Equity | $475.1M | $420.5M | $337.9M | $357.4M | $367.8M | |
| Total Debt | $298M | $232.8M | $229.2M | $252.4M | $276.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.1M | $71.4M | $63.4M | $28.8M | $35.3M | |
| Cash From Investing | -$47.1M | -$31.5M | -$43.5M | -$10.1M | -$14.7M | |
| Cash From Financing | -$86.8M | -$18.3M | -$25.1M | -$4.6M | -$7.6M | |
| Free Cash Flow | -$3.6M | $43.2M | $18.8M | $18.6M | $20.6M | |
IMAX
Sector
Market Cap
$1.3B
$112.8M
Price % of 52-Week High
91.36%
65.5%
Dividend Yield
0%
0%
Shareholder Yield
3.39%
3.52%
1-Year Price Total Return
64.56%
-15.05%
Beta (5-Year)
1.233
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$25.30
200-day SMA
Buy
Level
$19.48
Bollinger Bands (100)
Buy
Level
19.91 - 24.49
Chaikin Money Flow
Sell
Level
-32M
20-day SMA
Sell
Level
$25.63
Relative Strength Index (RSI14)
Sell
Level
44.76
ADX Line
Sell
Level
7.14
Williams %R
Buy
Level
-92.827
50-day SMA
Buy
Level
$23.91
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
60M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5193)
Sell
CA Score
(Annual)
Level (-0.7836)
Buy
Beneish M-Score
(Annual)
Level (-2.5738)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.6123)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Stock Forecast FAQ
In the current month, IMAX has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The IMAX average analyst price target in the past 3 months is $27.27.
-
Where Will Imax Stock Be In 1 Year?
According to analysts, the consensus estimate is that Imax share price will rise to $27.27 per share over the next 12 months.
-
What Do Analysts Say About Imax?
Analysts are divided on their view about Imax share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Imax is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is Imax's Price Target?
The price target for Imax over the next 1-year time period is forecast to be $27.27 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is IMAX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Imax is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IMAX?
You can purchase shares of Imax via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Imax shares.
-
What Is The Imax Share Price Today?
Imax was last trading at $24.53 per share. This represents the most recent stock quote for Imax. Yesterday, Imax closed at $24.52 per share.
-
How To Buy Imax Stock Online?
In order to purchase Imax stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
